Highest-materiality recent filing
Innovative Eyewear reports 65% sales growth in FY2025; management to buy shares
Preliminary FY2025 sales $2.7M, up 65% from $1.6M in FY2024.
Innovative Eyewear appoints Oswald Gayle as sole CFO; Dabrowski becomes Chief AI and Growth Officer
Konrad Dabrowski resigns as Co-CFO, appointed Chief AI and Growth Officer effective Nov 1, 2025.
Elected directors Harrison Gross, Kristen McLaughlin, Louis Castro, and Olivia Bartlett for terms until 2026.
Innovative Eyewear annual meeting adjourned due to lack of quorum; reconvenes Oct 24
Annual meeting held Oct 10, 2025 lacked quorum of common stock holders.
Innovative Eyewear annual meeting adjourned to Sep 12 due to lack of quorum
Annual meeting held August 26, 2025 failed to achieve quorum (no majority of common shares represented).
Innovative Eyewear increases shares available under ATM offering with H.C. Wainwright
Filed prospectus supplement on Aug 15, 2025 to increase max shares issuable under existing ATM facility.
Innovative Eyewear sets 2025 annual meeting for Aug 26, 2025; director nomination deadline July 10
2025 Annual Meeting scheduled for Tuesday, August 26, 2025.
Innovative Eyewear raises $4.8M in gross proceeds from warrant inducement and ordinary exercises
Gross proceeds $4.8M ($2.2M inducement + $0.3M new warrants + $2.6M ordinary exercises).
Innovative Eyewear raises $1.8M via warrant exercise at $2.60/sh; issues new warrants
Inducement agreements: holders exercise 595,188 warrants at reduced $2.60/sh; original prices $5.00 and $9.50.
Innovative Eyewear appoints Oswald Gayle as Co-Chief Financial Officer
Appointment effective October 11, 2024; Gayle will act as Principal Financial and Accounting Officer.
Innovative Eyewear adopts limited-duration rights plan with 20% trigger, expires Sept 25, 2025
One Right per share of common stock; exercise price $6.21 per share to purchase six shares.
Gross proceeds ~$2.6M from cash exercise of 263,160 existing warrants at $9.875/share.
Innovative Eyewear raises ~$762K from warrant exercise; issues Series C/D warrants
Exercised 148,567 existing warrants at $5.13/share for cash proceeds of ~$762,148.
Innovative Eyewear induces warrant exercise for ~$633K gross; new warrants issued
Reduced exercise price to $5.00/share from $21.00 to induce immediate cash exercise of 126,699 existing warrants.
Innovative Eyewear increases maximum shares available under ATM offering with H.C. Wainwright
Filed prospectus supplement on July 11, 2024 to increase max shares of common stock issuable under existing ATM facility.
Reverse stock split at 1:20 ratio effective July 16, 2024; trading on split-adjusted basis begins July 18, 2024.
Innovative Eyewear increases shares available under ATM offering with H.C. Wainwright
Filed prospectus supplement on June 12, 2024 to increase maximum shares under existing ATM facility.
Innovative Eyewear raises ~$2.5M in registered direct offering with warrants
Gross proceeds ~$2.5M; net ~$2.1M after placement agent fees and expenses.
Innovative Eyewear raises $1M in registered direct offering with warrants at $0.244/share
Gross proceeds ~$1M from 4,200,822 shares and warrants at combined $0.244/share; net proceeds ~$832,300.
Innovative Eyewear suspends at-the-market stock sales under ATM agreement
Suspended sales of common stock under ATM Agreement with H.C. Wainwright dated April 15, 2024.
Innovative Eyewear enters ATM equity offering of up to $1.12M with H.C. Wainwright
ATM agreement filed April 15, 2024 for up to $1,120,446 in common stock via H.C. Wainwright as sales agent.
On October 11, 2024, the Board of Directors of Innovative Eyewear Inc. (the “Company”) appointed Oswald Gayle as the Company’s Co-Chief Financial Officer, effective immediately.
Max materiality 0.65 · Median 0.50 · Most common event other_material